Sarepta Therapeutics
Trade Sarepta Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About SRPT
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
SRPT Key Statistics
Stock Snapshot
With a market cap of 2.28B, Sarepta Therapeutics(SRPT) trades at $21.55. The stock has a price-to-earnings ratio of -7.52.
During the trading session on 2025-12-12, Sarepta Therapeutics(SRPT) shares reached a daily high of $22.00 and a low of $18.83. At a current price of $21.55, the stock is +14.5% higher than the low and still -2.0% under the high.
Trading volume for Sarepta Therapeutics(SRPT) stock has reached 4.77M, versus its average volume of 3.19M.
The stock's 52-week range extends from a low of $10.42 to a high of $129.84.
The stock's 52-week range extends from a low of $10.42 to a high of $129.84.
SRPT News
Wedbush initiated coverage of Sarepta (SRPT) with an Outperform rating and $32 price target TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data...
In November 2025, Sarepta Therapeutics announced that the FDA had approved dosing in Cohort 8 of its ENDEAVOR trial, allowing evaluation of an enhanced immunosu...
